243 related articles for article (PubMed ID: 17626628)
21. Clear cell ependymoma: a mimicker of oligodendroglioma--report of three cases.
Jain D; Sharma MC; Arora R; Sarkar C; Suri V
Neuropathology; 2008 Aug; 28(4):366-71. PubMed ID: 18248576
[TBL] [Abstract][Full Text] [Related]
22. Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma.
Reardon DA; Entrekin RE; Sublett J; Ragsdale S; Li H; Boyett J; Kepner JL; Look AT
Genes Chromosomes Cancer; 1999 Mar; 24(3):230-7. PubMed ID: 10451703
[TBL] [Abstract][Full Text] [Related]
23. Angiocentric glioma: report of clinico-pathologic and genetic findings in 8 cases.
Preusser M; Hoischen A; Novak K; Czech T; Prayer D; Hainfellner JA; Baumgartner C; Woermann FG; Tuxhorn IE; Pannek HW; Bergmann M; Radlwimmer B; Villagrán R; Weber RG; Hans VH
Am J Surg Pathol; 2007 Nov; 31(11):1709-18. PubMed ID: 18059228
[TBL] [Abstract][Full Text] [Related]
24. [Significance of expression and secretion of interleukin-8 in ependymal tumor].
Gu J; Zhang X; Li X
Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):396-8. PubMed ID: 11798904
[TBL] [Abstract][Full Text] [Related]
25. Anaplastic ependymoma with ependymoblastic multilayered rosettes.
Nobusawa S; Suzuki A; Nagaishi M; Isoda K; Ikota H; Yokoo H; Hirato J; Nakazato Y
Hum Pathol; 2013 Nov; 44(11):2597-602. PubMed ID: 23791209
[TBL] [Abstract][Full Text] [Related]
26. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel regions of allelic loss in ependymomas by high-resolution allelotyping with 384 microsatellite markers.
Tong CY; Zheng PP; Pang JC; Poon WS; Chang AR; Ng HK
J Neurosurg; 2001 Jul; 95(1):9-14. PubMed ID: 11453403
[TBL] [Abstract][Full Text] [Related]
28. Chromosomal characteristics of neurogenic tumors in children.
Mark J
Acta Cytol; 1970; 14(8):510-8. PubMed ID: 4322992
[No Abstract] [Full Text] [Related]
29. Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups.
Dyer S; Prebble E; Davison V; Davies P; Ramani P; Ellison D; Grundy R
Am J Pathol; 2002 Dec; 161(6):2133-41. PubMed ID: 12466129
[TBL] [Abstract][Full Text] [Related]
30. Immune gene and cell enrichment is associated with a good prognosis in ependymoma.
Donson AM; Birks DK; Barton VN; Wei Q; Kleinschmidt-Demasters BK; Handler MH; Waziri AE; Wang M; Foreman NK
J Immunol; 2009 Dec; 183(11):7428-40. PubMed ID: 19917695
[TBL] [Abstract][Full Text] [Related]
31. Clear cell ependymoma with trisomy 19 developing bone metastases.
Payet M; Conter C; Labrousse F; De Paula AM; Marabelle A; Branger DF; Bouvier R; Frappaz D
Childs Nerv Syst; 2012 May; 28(5):739-42. PubMed ID: 22207400
[No Abstract] [Full Text] [Related]
32. Molecular analysis of genetic changes in ependymomas.
Bijlsma EK; Voesten AM; Bijleveld EH; Troost D; Westerveld A; Mérel P; Thomas G; Hulsebos TJ
Genes Chromosomes Cancer; 1995 Aug; 13(4):272-7. PubMed ID: 7547635
[TBL] [Abstract][Full Text] [Related]
33. Molecular cytogenetic studies of pediatric ependymomas.
Kramer DL; Parmiter AH; Rorke LB; Sutton LN; Biegel JA
J Neurooncol; 1998 Mar; 37(1):25-33. PubMed ID: 9525835
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid cytology in patients with ependymoma: a bi-institutional retrospective study.
Qian X; Goumnerova LC; De Girolami U; Cibas ES
Cancer; 2008 Oct; 114(5):307-14. PubMed ID: 18698591
[TBL] [Abstract][Full Text] [Related]
35. Multiple chromosomal monosomies are characteristic of giant cell ependymoma.
Dahlback HS; Brandal P; Krossnes BK; Fric R; Meling TR; Meza-Zepeda LA; Danielsen HE; Heim S
Hum Pathol; 2011 Dec; 42(12):2042-6. PubMed ID: 21683982
[TBL] [Abstract][Full Text] [Related]
36. Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3.
Suarez-Merino B; Hubank M; Revesz T; Harkness W; Hayward R; Thompson D; Darling JL; Thomas DG; Warr TJ
Neuro Oncol; 2005 Jan; 7(1):20-31. PubMed ID: 15701279
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma.
Pezzolo A; Capra V; Raso A; Morandi F; Parodi F; Gambini C; Nozza P; Giangaspero F; Cama A; Pistoia V; Garrè ML
Cancer Lett; 2008 Mar; 261(2):235-43. PubMed ID: 18179864
[TBL] [Abstract][Full Text] [Related]
38. [Pathomorphology of ependymal tumors with special reference to their mode of proliferation].
Kaluza J; Gutowska-Maciagowa A
Patol Pol; 1975; 26(3):409-22. PubMed ID: 1208150
[No Abstract] [Full Text] [Related]
39. Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells.
Nijssen PC; Deprez RH; Tijssen CC; Hagemeijer A; Arnoldus EP; Teepen JL; Holl R; Niermeyer MF
J Neurol Neurosurg Psychiatry; 1994 Oct; 57(10):1245-8. PubMed ID: 7931388
[TBL] [Abstract][Full Text] [Related]
40. Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling.
Figarella-Branger D; Lechapt-Zalcman E; Tabouret E; Jünger S; de Paula AM; Bouvier C; Colin C; Jouvet A; Forest F; Andreiuolo F; Quintin-Roue I; Machet MC; Heitzmann A; Milin S; Sevestre H; Godfraind C; Labrousse F; Metellus P; Scavarda D; Pietsch T
Neuro Oncol; 2016 Jul; 18(7):919-27. PubMed ID: 26984744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
